Analysis of circulating tumor cells (CTC) from the blood is an attractive alternative to invasive and painful biopsy for cancer diagnosis. However, their low abundance, blood cell contamination and cell death during purification have created obstacles for the successful clinical adoption of this technology. In order to circumvent these problems, researchers turned to single-cell technology to enrich CTC from the blood and determine tumor characteristics.
Download this application note from BioRad to learn
The Scientist c/o LabX Media Group 1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: email@example.com